Physician profile
Christopher Cl Ng
NPI 1790711588
$502.38
in general payments reported to CMS, 2019-2025
10 companies · $155 in 2025
The $155 reported for 2025 was more than what 76% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.28 · 2021: $42.39 · 2022: $31.98 · 2023: $61.25 · 2024: $189 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $169.18 | 2019-2024 | Provenge |
| Dornier Medtech America, INC | $102.06 | 2025 | Dornier Medtech |
| Laborie Medical Technologies Corp. | $43.06 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.39 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $38.94 | 2022-2023 | Imfinzi |
| Astellas Pharma US INC | $30.49 | 2025 | Xtandi |
| Progenics Pharmaceuticals, INC. | $28.30 | 2023 | Pylarify |
| Janssen Biotech, INC. | $21.97 | 2025 | Erleada |
| Abc Home Medical Supply, INC. | $13.14 | 2023 | |
| Teleflex LLC | $12.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.